pathological complete remission (pcr) of breast cancer following neoadjuvant chemotherapy (nact)
Published 6 years ago • 130 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:45
association of pathologic complete response following neoadjuvant chemotherapy with longterm sur...
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
6:54
no pcr in patients after neoadjuvant chemotherapy in tnbc
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
3:39
steps for patients who do not receive complete response after neoadjuvant therapy
-
1:38
compassher2-pcr: de-escalation of neoadjuvant chemotherapy for breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
1:33
role & evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy
-
1:28
dual her2 blockade in patients with her2-positive breast cancer after pcr
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
5:55
utilizing pathologic complete response in breast cancer trials
-
3:50
pcr associated with significantly reduced risks of efs events
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
-
17:42
what do we do after complete response to neoadjuvant therapy?
-
19:35
treatment options in patients with residualr (tnbc) following neoadjuvant ctx dr. meteb al-foheidi
-
1:40
predicting pathological complete response in breast cancer
-
20:24
neoadjuvant chemotherapy for breast cancer - time to rethink. 27jul22
-
7:44
prediction of pcr by hrd after carboplatin neoadjuvant chemotherapy in tnbc patients
-
31:25
imaging of neo adjuvant therapy in breast cancer treatment